Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.

Jacob S AdayBoris D HeifetsSteven D PratscherEllen BradleyRaymond RosenJoshua D Woolley

Published in: Psychopharmacology (2022)

Incorporating the recommended design elements is intended to reduce the risk of bias in psychedelic clinical trials and thereby increases the ability to discern treatment-specific effects of psychedelic therapy.

Keyphrases

clinical trial
phase ii
open label
phase iii
clinical practice
randomized controlled trial
double blind
stem cells
study protocol
replacement therapy
mesenchymal stem cells
bone marrow
smoking cessation